Panelists explore new approaches to beta cell replacement for type 1 diabetes
Beta cell replacement, usually by islet transplant, works but is used in only 5-10% of people with type 1 diabetes, explained Andrew R. Pepper, PhD. Limited supplies of beta cells, survival of grafts post transplantation, the lifelong need for immune suppression, and the risks inherent in cell transplantation are all barriers to this therapy.
Read more